↓ Skip to main content

Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis

Overview of attention for article published in Cancer and Metastasis Reviews, August 2010
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
202 Dimensions

Readers on

mendeley
166 Mendeley
Title
Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis
Published in
Cancer and Metastasis Reviews, August 2010
DOI 10.1007/s10555-010-9239-y
Pubmed ID
Authors

Limin Shu, Ka-Lung Cheung, Tin Oo Khor, Chi Chen, Ah-Ng Kong

Abstract

Carcinogenesis is a multi-step process which could be prevented by phytochemicals. Phytochemicals from dietary plants and other plant sources such as herbs are becoming increasingly important sources of anticancer drugs or compounds for cancer chemoprevention or adjuvant chemotherapy. Phytochemicals can prevent cancer initiation, promotion, and progression by exerting anti-inflammatory and anti-oxidative stress effects which are mediated by integrated Nrf2, NF-kappaB, and AP-1 signaling pathways. In addition, phytochemicals from herbal medicinal plants and/or some dietary plants developed in recent years have been shown to induce apoptosis in cancer cells and inhibition of tumor growth in vivo. In advanced tumors, a series of changes involving critical signaling molecules that would drive tumor cells undergoing epithelial-mesenchymal transition and becoming invasive. In this review, we will discuss the potential molecular targets and signaling pathways that mediate tumor onset and metastasis. In addition, we will shed light on some of the phytochemicals that are capable of targeting these signaling pathways which would make them potentially applicable to cancer chemoprevention, treatment and control of cancer progression.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Japan 1 <1%
Croatia 1 <1%
Lebanon 1 <1%
Unknown 162 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 32 19%
Student > Master 28 17%
Researcher 17 10%
Student > Bachelor 13 8%
Student > Doctoral Student 8 5%
Other 24 14%
Unknown 44 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 37 22%
Biochemistry, Genetics and Molecular Biology 23 14%
Pharmacology, Toxicology and Pharmaceutical Science 15 9%
Medicine and Dentistry 10 6%
Nursing and Health Professions 6 4%
Other 22 13%
Unknown 53 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2013.
All research outputs
#20,198,525
of 22,716,996 outputs
Outputs from Cancer and Metastasis Reviews
#737
of 807 outputs
Outputs of similar age
#89,226
of 93,991 outputs
Outputs of similar age from Cancer and Metastasis Reviews
#17
of 18 outputs
Altmetric has tracked 22,716,996 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 807 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,991 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.